Smith & Wesson: Is the Gun Run Done?

Written by GSCR Staff   
Wednesday, 09 December 2015 08:04

Our theme for Monday’s Goldman Guide was ‘Opportunity Knocks’. It is impossible to ignore the run that gun manufacturer Smith &Wesson Holding Corporation (NASDAQ – SWHC - $21.390) has had over the past week or so.

The stock has climbed nearly $3 since the inevitable and latest demonization of guns from the POTUS after the Paris and California terrorist attacks. The chart below illustrates the 800% climb the stock has had since Mr. Obama took office! No doubt he will be asked to be on the Board of Directors when he becomes a private citizen again in a little over a year.

SWHC7-Year Chart

(Source: www.otcmarkets.com)

MM.12.09.15.SWHC-7yr

We have featured SWHC in the Market Monitor and as a 30-30 pick over the last few years with the first highlight coming in April 2013 at $8.36. It has been a nice run for us with a 150% increase since that time. The question is, how long will this run last which has predominately fueled by political forces.

Yesterday, the Company reported 2QFY16 financial results and the news was positive for the most part. Revenue of $143.2 million and EPS of $0.22 beat estimates of $130 million and $0.18 respectively. Additionally, the Company raised expectations for FY 2016 to $630M from $610M, representing a 14% increase over FY 2015. This puts the forward P/E at 14 versus the trailing of 23. The revenue picture looks solid going forward.

If we step back and look at SWHC from a trading perspective the stock also looks promising. The short, intermediate, and long term EMA are all very bullish.

Finally, when margins are examined the signs also point in the right direction. The gross margin of 37% is 13% higher than the industry average while theoperating margin of 17% is also well above the industry average of 11%.

At the end of the day, the metrics indicate SWHC is a solid investment regardless of the political party in the White House. If the GOP gains control next year we doubt another 800% climb will occur in over a 7-year period. However, we still think SWHC is worth holding onto and believe the stock can climb to $25 in the first six months of 2016.

Have a great day!

Goldman Small Cap Research is not affiliated in any way with Goldman Sachs & Co.

It is important to note that while we may track performance separately, we utilize the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company’s individual disclosures for each engagement, which can be found in each company-specific report. All information contained in this blog, newsletter and in our reports were provided by the Companies or generated from our own due diligence. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence. Analysts are compensated on a per report basis and not on the basis of his/her recommendations. 

The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, or other firms. Goldman Small Cap Research relied solely upon information provided by the Company through its filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small CapResearch blog, report, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed.

This blog does not take into account the investment objectives, financial situation, or particular needs of any particular person. This blog does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with FINRA or with any state securities regulatory authority.

ALL INFORMATION IN THIS BLOG, REPORT OR NEWSLETTER IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLECONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS   INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLECONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.

For more information, visit our Disclaimer: www.goldmanresearch.com

Add comment
  • No comments found